Results

eNauka >  Results >  Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
Title: Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial
Authors : Steg, Philippe Gabriel; ...; Dilić, Mirza; ...; Ristić, Arsen D.  ; ...; Miličić, Davor; ...; Simić, Dragan V.  ; Ivanović, Nikola;
Davidović, Goran T.  ; Tasić, Nebojša M.; Ašanin, Milika R.  ; Stojić, Stevo; Apostolović, Svetlana R.  ; Ilić, Stevan N.; Putniković, Biljana ; Stanković, Aleksandar; Aranđelović, Aleksandra C. ; Radovanović, Slavica ; Balinovac, Jovan; Dinčić, Dragan V.  ; Seferović, Petar M. ; Dodić, Slobodan S.; Dimković, Siniša ; ...; (broj, koautora 1581);
Issue Date: 2019
Publication: CIRCULATION
ISSN: 0009-7322 e1524-4539 Circulation
Publisher: Lippincott Williams & Wilkins, Hagerstown
Type: Article
Collation: vol. 140 br. 2 str. 103-112
DOI: 10.1161/CIRCULATIONAHA.118.038840
WoS-ID: 000476768100007
Scopus-ID: 2-s2.0-85068168207
PMID: 31117810
PMCID: PMC6661243
URI: https://enauka.gov.rs/handle/123456789/814089
URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6661243/pdf/cir-140-103.pdf
Project: Sanofi
Regeneron Pharmaceuticals, Inc.
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
21aM21a

114
SCOPUSTM
35
PubMed CentralTM
83
OpenCitations
105
WEB OF SCIENCETM
Altmetric
Dimensions

Report a mistake

This message will be sent to your editor

Description field cannot be empty

Find the DOI
Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.